Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JANUARY 14, 2022

Right-to-try aims to allow patients who have been diagnosed with life-threatening diseases or conditions who have tried all approved treatment options and who are unable to participate in a clinical trial to access certain unapproved treatments. Right-to-try permits those patients to have access to investigational drugs.

Treatment 52

Treatment Access Clinical Trials Patients 52

NORML

JANUARY 19, 2020

House Bill 1359 would create a 5 year medical marijuana pilot program, allowing patients to access their medicine from licensed dispensaries. Send a message to your lawmakers in support of medical marijuana access. Legislation is pending, Senate Bill 697, to expand access to medical marijuana. IN resident? NH resident?

Legislation 252

Legislation Decriminalization Access Patients 252

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Canna Care Docs

MARCH 27, 2025

This trend raises important questions about access, affordability, and the future of medical cannabis as a vital healthcare resource. The program aimed to provide safe, legal access to cannabis for patients with chronic conditions. This decrease has raised concerns about access to cannabis-based treatments for those who need them most.

Programs 52

Programs Recreational Dispensary Patients 52

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021. With these injustices, and many more, it is clear why many BIPOC might be disinterested in participating in such studies today.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

Veriheal

MAY 22, 2023

In April 2023, Maine’s Office of Cannabis Policy (OCP) reported an exodus of about 1350 cannabis primary caregivers from the state’s medical marijuana market between 2021 to January 2023. A caregiver is trained to handle up to five patients diagnosed with any of the qualifying health issues for medical cannabis treatment.

Programs 95

Programs Patients Policy Cannabis 95

Cannabis Law Report

JULY 29, 2021

VANCOUVER, BC, July 29, 2021 /CNW/ – Levitee Labs Inc. These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. In consideration for the acquisition, Levitee paid $350,000 in cash on the closing date.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. 19 August 2021. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.

Data 105

Data Access Medicine Patients 105

The Cannigma

JULY 12, 2022

Alabama law does not allow the consumption, possession, or cultivation of marijuana for recreational purposes, but has approved the establishment of a medical marijuana program in February 2021. The same bill was introduced in 2021 but failed in the Senate Chamber. How do people in Alabama view marijuana? CBD regulations.

Legalization 142

Legalization Chronic Pain Programs Epilepsy 142

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

The Cannigma

SEPTEMBER 28, 2021

A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana. Medical cannabis was started in 2021 under specific conditions in limited products only in Ireland (Shutterstock). However, Irish law does allow the sale of CBD.

Law 97

Law Marijuana Treatment Epilepsy 97

The Cannigma

SEPTEMBER 28, 2021

A poll in May 2021 found that nearly 40% of Irish citizens support legalizing cannabis for recreational use, and over 90% support the legalization of medical marijuana. Medical cannabis was started in 2021 under specific conditions in limited products only in Ireland (Shutterstock). However, Irish law does allow the sale of CBD.

Law 96

Law Marijuana Treatment Epilepsy 96

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The post France Wants to Experiment With Giving Away Free Medical Cannabis in 2021 appeared first on Cannabis Central.

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Cannabis Law Report

JANUARY 11, 2022

Legal cannabis partnership to help patient access. MiDispensary burst onto the scenes in August 2021, offering Australians high quality treatment at an affordable yearly fee. MiDispensary burst onto the scenes in August 2021, offering Australians high quality treatment at an affordable yearly fee.

Access 52

Access Patients Clinical Trials Legalization 52

Cannabis Law Report

JANUARY 6, 2022

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. On December 15, 2021, the non-profit organization Freedom to Operate (FTO) filed a post-grant review filing to challenge a U.S. patent awarded to COMPASS back in March 2021. The Race to Patent Psilocybin.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 81

Business Research and Development Environment Food 81

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

WeedAdvisor

MARCH 19, 2019

The study, which began in 2016 and is set to conclude in 2021, began by assessing the therapeutic effects of CBD in animals with brain injuries. Researchers found that complementary CBD therapy in conjunction with conventional treatment yielded better results. Currently No Medication for Concussions. . Holtz, who holds a Ph.D

Treatment 53

Treatment CBD Research and Development Therapy 53

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. One of our main goals is to increase the accessibility and affordability of medical cannabis as a treatment.”

Patients 98

Patients Treatment Environment Conditions 98

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. The Marijuana Regulatory Agency issued a request for proposals for the 2021 Veteran Marijuana Research Grant Program on Tuesday, June 1.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

The Cannigma

JULY 5, 2022

A 2021 bill expanded legal products to also include transdermal patches, lotions, and capsules, none of which can currently be legally purchased. There were bills introduced during the 2021 and 2022 legislative sessions to reduce the penalties for possession and jumpstart the licensing process, but they did not pass.

Law 119

Law Decriminalization Programs Patients 119

MMJ Recs

JANUARY 5, 2021

In 2020 alone, the increase in legalization of medical marijuana gave people access to the treatment as long as they have a condition that is certified to be managed with its use. In 2021, more changes are likely to occur in regards to the laws and regulations surrounding the use of MMJ. 2021 Medical Marijuana Laws.

Marijuana 52

Marijuana Treatment Conditions Chronic Pain 52

Cannabis Law Report

JUNE 20, 2021

On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. .

Research and Development 98

Research and Development Therapy Treatment Access 98

Cannabis Law Report

DECEMBER 26, 2021

Published: Dec 21, 2021. 21, 2021 /PRNewswire/ — Ixtlan Bioscience , a biotech company focused on developing psilocybin-based treatment for Alzheimer’s Disease and Brain Pathologies, has announced today the filing of a new Provisional Patent with the United States Patent and Trademark Office (USPTO) Application No.

Treatment 52

Treatment Patients Data Access 52

The Cannigma

SEPTEMBER 13, 2021

In July, 2021, Israeli lawmakers rejected a bill that would have decriminalized recreational marijuana use. The medical cannabis program in Israel is not as lenient as those in many other countries, and patients typically are required to attempt other medical treatments before cannabis is approved.

Legalization 124

Legalization Decriminalization Patients Cannabis 124

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

The Cannigma

JULY 24, 2022

The most recent medical marijuana bill , introduced in 2021, would have created a program, albeit a restrictive one. It expanded qualifying conditions and allowed patients to access select THC products through state-licensed dispensaries. South Carolina medical marijuana program. The state does not have a medical program.

Law 137

Law THC Hash Oil 137

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

APRIL 21, 2021

According to the 2021 State of Mental Health in America by nonprofit organization Mental Health America (MHA), 19% of adults experienced a mental illness between 2017 and 2018, an increase of 1.5 One of the major obstacles many with a mental illness face is access to and affordability of treatment and resources.

Conditions 98

Conditions Treatment Patients Cannabis 98

MMJ Recs

AUGUST 25, 2021

Dispensaries have opened up for business all across the state, but which Pennsylvania dispensaries are leading the pack and bringing patients the best service in 2021? Image by StayRegular on Pixabay : What do Pennsylvania dispensaries sell in 2021? How Do You Get A Pennsylvania MMJ Card In 2021? PA Dispensary Prices.

Dispensary 52

Dispensary Conditions Patients Education 52

Cannabis Law Report

AUGUST 2, 2021

CHICAGO , July 15, 2021 /PRNewswire/ — P alo Santo , the leading U.S.-based In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Here’s the press release. Tweet this.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Cannabis Law Report

JULY 22, 2021

VANCOUVER, BC, July 22, 2021 /CNW/ – Levitee Labs Inc. A review of the Company’s recent achievements and current business is as follows: On July 14 th , 2021, Levitee launched its premium mushroom supplement blends MONKE into the North American market on major eCommerce platforms, including Amazon. About Levitee Labs.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

AUGUST 16, 2021

Vancouver, B.C. – August 12, 2021 – Origin Therapeutics Holdings Inc. We plan to deploy capital across a diverse group of private companies to offer our investors exposure to early-stage opportunities with high growth potential that they may otherwise be unable to access.”. per warrant. “We

Treatment 105

Treatment Access Business 105

Cannabis Law Report

SEPTEMBER 10, 2021

9, 2021 /PRNewswire/ — PsiloThera, Inc. PsiloThera’s clinical focus is the development of treatments for Mental Illnesses, Cognitive Diseases & Neurological Disorders. HENDERSON, Nev. , Sept. Patents Protecting Its Proprietary Psychedelic Therapeutic Process and Tele-Mental Health & Microdosing Platform.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). Nov 24 2021.

Patients 98

Patients Education Marijuana Therapy 98